Investigating the Inverted-U Relationship Between Cognitive Performance and Plasma Epinephrine
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
Abstract Although acute resistance exercise has been suggested to enhance inhibitory control, a critical component of executive function, the mechanism by which acute exercise influences inhibitory control is unclear and there are methodological limitations in previous empirical studies. According to the locus coeruleus-norepinephrine (LC-NE) theory, the activity of the LC, the major releaser of NE in the brain, regulates inhibitory control. Because there is reciprocal communication between circulating epinephrine and the LC. Plasma epinephrine is chosen as the index of LC-NE activity. However, only one study in acute exercise-inhibitory control measured the plasma epinephrine. Therefore, this registered report aims to extend its findings by a four-arm crossover randomized controlled design with three different intensities, using free-weight, multiple-joint, and structural resistance exercises. Moreover, most studies showed some methodological limitations such as failing to report the process of randomization, implementing a familiarization of resistance exercise before the maximal strength test, and publishing the protocol. Without a transparent report on how the participants were allocated, the results were at risk of bias. Without a familiarization of resistance exercise, the maximal muscle strength was likely to be underestimated. Without publishing the protocol before data collection, these findings were threatened by undetected researchers' degrees of freedom such as HARKing (hypothesizing after the results are known), cherry picking, and p-hacking. This registered report will address the limitations of previous studies by incorporating cognitive and resistance exercise familiarization, transparently reporting the randomization process, and submitting it as a registered report.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2022
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 26, 2022
CompletedStudy Start
First participant enrolled
June 1, 2022
CompletedFirst Posted
Study publicly available on registry
June 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedJune 9, 2022
June 1, 2022
1.3 years
May 26, 2022
June 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Inhibitory control (change between baseline and 5 minutes after intervention/control)
The Inhibitory control (Stroop interference score) will be the mean incongruent reaction time minus the mean congruent reaction time. Lower scores mean a better outcome.
Baseline (before intervention) and 5 minutes after (post-task) intervention/control.
Inhibitory control (change between baseline and 20 minutes after intervention/control)
The Inhibitory control (Stroop interference score) will be the mean incongruent reaction time minus the mean congruent reaction time. Lower scores mean a better outcome.
Baseline (before intervention) and 20 minutes after (post-task) intervention/control.
Inhibitory control (change between baseline and 35 minutes after intervention/control)
The Inhibitory control (Stroop interference score) will be the mean incongruent reaction time minus the mean congruent reaction time. Lower scores mean a better outcome.
Baseline (before intervention) and 35 minutes after (post-task) intervention/control.
Inhibitory control (change between baseline and 50 minutes after intervention/control)
The Inhibitory control (Stroop interference score) will be the mean incongruent reaction time minus the mean congruent reaction time. Lower scores mean a better outcome.
Baseline (before intervention) and 50 minutes after (post-task) intervention/control.
Information processing speed (change between baseline and 5 minutes after intervention/control)
The Information processing speed will be the mean simple reaction time. Lower scores mean a better outcome.
Baseline (before intervention) and 5 minutes after intervention/control.
Information processing speed (change between baseline and 20 minutes after intervention/control)
The Information processing speed will be the mean simple reaction time. Lower scores mean a better outcome.
Baseline (before intervention) and 20 minutes after intervention/control.
Information processing speed (change between baseline and 35 minutes after intervention/control)
The Information processing speed will be the mean simple reaction time. Lower scores mean a better outcome.
Baseline (before intervention) and 35 minutes after intervention/control.
Information processing speed (change between baseline and 50 minutes after intervention/control)
The Information processing speed will be the mean simple reaction time. Lower scores mean a better outcome.
Baseline (before intervention) and 50 minutes after intervention/control.
Secondary Outcomes (5)
Epinephrine (change between baseline and immediately after intervention/control)
Baseline and immediately after intervention/control.
Epinephrine (change between baseline and 15 minutes after intervention/control)
Baseline and 15 minutes after intervention/control.
Epinephrine (change between baseline and 30 minutes after intervention/control)
Baseline and 30 minutes after intervention/control.
Epinephrine (change between baseline and 45 minutes after intervention/control)
Baseline and 45 minutes after intervention/control.
Epinephrine (change between baseline and 60 minutes after intervention/control)
Baseline and 60 minutes after intervention/control.
Study Arms (4)
Control condition
NO INTERVENTIONDuring the control condition, participants will be asked to read a book related to exercise for approximately 40 minutes.
Low-intensity barbell resistance exercise
EXPERIMENTALExercise: Barbell squat, barbell press, and barbell deadlift Number of sets: 3 Number of repetitions: 5 Intensity: 65% 1RM Training method: Circuit training (Squat set 1 ➔ Press set 1 ➔ Deadlift set 1 ➔ Squat set 2 ➔ Press set 2 ➔ Deadlift set 2 ➔ Squat set 3 ➔ Press set 3 ➔ Deadlift set 3) Rest interval between exercises and sets: \~3 minutes (Warm-up: 1 set of 5 repetitions for each exercise at 50% 1RM)
Moderate-intensity barbell resistance exercise
EXPERIMENTALExercise: Barbell squat, barbell press, and barbell deadlift Number of sets: 3 Number of repetitions: 5 Intensity: 72% 1RM Training method: Circuit training (Squat set 1 ➔ Press set 1 ➔ Deadlift set 1 ➔ Squat set 2 ➔ Press set 2 ➔ Deadlift set 2 ➔ Squat set 3 ➔ Press set 3 ➔ Deadlift set 3) Rest interval between exercises and sets: \~3 minutes (Warm-up: 1 set of 5 repetitions for each exercise at 50% 1RM)
High-intensity barbell resistance exercise
EXPERIMENTALExercise: Barbell squat, barbell press, and barbell deadlift Number of sets: 3 Number of repetitions: 5 Intensity: 78% 1RM Training method: Circuit training (Squat set 1 ➔ Press set 1 ➔ Deadlift set 1 ➔ Squat set 2 ➔ Press set 2 ➔ Deadlift set 2 ➔ Squat set 3 ➔ Press set 3 ➔ Deadlift set 3) Rest interval between exercises and sets: \~3 minutes (Warm-up: 1 set of 5 repetitions for each exercise at 50% 1RM)
Interventions
There will be four conditions (three exercises and one control) on visits 3-6. For the three exercise conditions, all training parameters except intensity will be the same. The sets in high, moderate, and low intensity correspond to the rate of perceived exertion (0-10 scale) 7-9, 5-6, and 3-4, respectively. Therefore, the participants will perform 5 repetitions barbell squat, barbell press, and barbell deadlift with 8RM (78% 1RM), 11RM (72% 1RM), and 16RM (65% 1RM) for 3 sets
Eligibility Criteria
You may qualify if:
- healthy young male aged 18-40 years;
- recreational resistance-trained (≥ 1 time/week for the previous 6 months);
- free from cardiovascular, cerebrovascular, and neurological disorders and other chronic diseases;
- free from any medical condition listed on the 2014 update of the Physical Activity Readiness Questionnaire (PAR-Q+);
- non-smoker; and
- normal or corrected-to-normal vision.
You may not qualify if:
- athlete trained in a competitive sports team or engaging in exercise for more than 20 hours/week;
- unable to perform any of the intervention exercises (barbell squat, press, and deadlift); or
- color blind
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Blinding (masking) and controlling risk of bias Because of the nature of exercise interventions, the blinding of participants and experimenters is not applicable to our study. To reduce the threat of the placebo effect, we will ask participants for their expectations on cognitive performance, and these will be incorporated into our statistical analysis. Blinding of the outcome assessors is also not possible. However, all measurements of cognitive performance will be computerized and not involve human judgment. The data analyzers will not be blinded but will follow a pre-specified statistical analysis plan. These procedures will reduce the risk of bias arising from the lack of blinding of participants, experimenters, assessors, and data analyzers and the threat from researchers' degrees of freedom.
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 26, 2022
First Posted
June 7, 2022
Study Start
June 1, 2022
Primary Completion
September 30, 2023
Study Completion
December 31, 2023
Last Updated
June 9, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- The study protocol is available on Open Science Framework (https://osf.io/4fkpc/). The raw data will be published after the trial is completed. (No time limitation imposed)
- Access Criteria
- No limitation.
We will publish the raw data online when we submit the resulting manuscript.